KMPUR.E — Kimteks Poliuretan Sanayi Ve Ticaret AS Balance Sheet
0.000.00%
- TRY7.97bn
- TRY11.36bn
- TRY13.24bn
- 17
- 67
- 33
- 28
Annual balance sheet for Kimteks Poliuretan Sanayi Ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 327 | 554 | 2,375 | 3,290 | 826 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 486 | 1,072 | 3,174 | 4,377 | 4,785 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 966 | 2,071 | 6,741 | 8,816 | 7,791 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 72.5 | 111 | 848 | 1,294 | 1,619 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,065 | 2,208 | 7,722 | 10,226 | 9,706 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 778 | 1,630 | 4,566 | 6,556 | 7,010 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 790 | 1,644 | 5,207 | 7,110 | 7,067 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 275 | 564 | 2,515 | 3,116 | 2,639 |
Total Liabilities & Shareholders' Equity | 1,065 | 2,208 | 7,722 | 10,226 | 9,706 |
Total Common Shares Outstanding |